PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Intensive Care Unit, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.\', \'Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.\', \'Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria.\', \'Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria.\', \'Department of Internal Medicine, Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria.\', \'Department of Internal Medicine, Division of Nephrology, Medical University of Graz, Graz, Austria.\', \'Department of Internal Medicine, Division of Angiology, Medical University of Graz, Graz, Austria.\', \'Department of Internal Medicine, Intensive Care Unit, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria. philipp.eller@medunigraz.at.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-96352-1
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34471146
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all